SOURCE: MyDx, Inc.

MyDx, Inc.

July 01, 2015 08:30 ET

MyDx to Host Virtual Roadshow on July 15, 2015

SAN DIEGO, CA--(Marketwired - July 01, 2015) - MyDx, Inc. (OTCQB: MYDX), creator of MyDx (My Diagnostic), the first handheld chemical analyzer for consumers, will host a virtual roadshow and webcast on Wednesday, July 15, 2015 at 8:00 a.m. Pacific time (11:00 a.m. Eastern time) to provide investors with a detailed overview of the company and outline the strategy for growth.

Investor Conference Call & Webcast
Presenters: Skip Sanzeri, President & Tom Gruber, CFO
Date: Wednesday, July 15, 2015
Time: 8:00 a.m. Pacific time (11:00 a.m. Eastern time)
Conference ID: 1989872
U.S. Dial-In: 1-888-329-8862
International Dial-In: 1-719-325-2393
Webcast: http://public.viavid.com/index.php?id=115054

Please dial in at least 10 minutes before the call to ensure timely participation.

A playback of the call will be available through August 15, 2015. To listen, call 1-877-870-5176 within the United States or 1-858-384-5517 when calling internationally. Please use the replay pin number 1989872. An archived webcast of the call will be available on the Company's website at http://ir.cdxlife.com.

About MyDx, Inc.

MyDx, Inc. (OTCQB: MYDX) is a science and technology company based in San Diego, California whose mission is to empower people to live a healthier life by revealing the chemicals in what they eat, drink and inhale. The Company has developed MyDx, a portable analyzer that provides real-time chemical analysis and fits in the palm of your hands. MyDx leverages over a decade of established electronic nose technology to measure chemicals of interest and has four sensors being developed in its lab that are compatible with the MyDx App. For more information, please visit www.cdxlife.com.

Safe Harbor

This news release contains "forward-looking statements" as that term is defined in Section 27(a) of the Securities Act of 1933, as amended, and Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements may contain certain forward-looking statements pertaining to future anticipated or projected plans, performance and developments, as well as other statements relating to future operations and results. Any statements in this press release that are not statements of historical fact may be considered to be forward-looking statements. Words such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," or variations of these or similar words, identify forward-looking statements. These forward-looking statements by their nature are estimates of future results only and involve substantial risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, our ability to complete our product testing and launch our product commercially, the acceptance of our product in the marketplace, the uncertainty of the laws and regulations relating to cannabis, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed from time to time in our reports filed with the Securities and Exchange Commission, available at www.sec.gov.

Contact Information

  • Company Contact:
    MyDx, Inc.
    Skip Sanzeri
    President
    Tel 1-800-814-4550
    skip@cdxlife.com

    Investor Relations Contact:
    MZ North America
    Greg Falesnik
    Senior Vice President
    Tel 1-949-385-6449
    Greg.Falesnik@mzgroup.us